M42, a global health leader powered by AI and genomics, has signed an agreement with Arcera, a global life sciences company, to formalise a strategic, non-exclusive collaboration focused on advancing biopharma localisation, clinical development and next-generation healthcare innovation in Abu Dhabi.
Dubai's healthcare and immigration authorities are set to introduce a more seamless treatment journey for international patients under a new partnership aimed at strengthening the emirate's position as a global health tourism destination.
Fuelled by unusually warm ocean waters in the tropical Pacific, El Niño conditions are developing and are set to influence global temperature and rainfall patterns, increasing the risk of extreme weather over the coming months, according to the World Meteorological Organization (WMO).
The Emirates Drug Establishment (EDE) has approved Wegovy (semaglutide), an oral once-daily treatment indicated for long-term weight management in adults living with obesity or overweight associated with weight-related medical conditions.
Al Ain Farms Group (AAFG), one of the UAE’s largest food and beverage (F&B) manufacturers, has announced a major step in its commitment to improving public health by pledging to reduce added sugars by 10-20 per cent across its brands, including Al Ain Farms and Marmum Dairy.
The GCC countries recorded a 3 percent decline in the annual rate of groundwater extraction over the past nine years, alongside an increase in the share of renewable water resources, which reached 25.5 percent in 2024.
The UAE's Ministry of Foreign Affairs (MoFA) has advised UAE nationals and residents against travel to Uganda, the Democratic Republic of the Congo, and South Sudan unless absolutely necessary in light of the evolving public health situation related to ebola virus disease (EVD).
The Ebola outbreak in the Democratic Republic of the Congo (DRC) has intensified, with the number of suspected cases crossing 1,000 and neighbouring Uganda imposing emergency border restrictions amid fears of wider regional spread.
Climate finance has continued to grow with developed countries providing and mobilising $132.8 billion in climate finance for developing countries in 2023 and $136.7 billion in 2024, according to new OECD data.
Novo Nordisk, a global pharmaceutical company and a leader in developing treatments for diabetes, obesity and rare diseases, has announced the establishment of a regional distribution centre in the UAE, further reinforcing the country’s position as a global hub for pharmaceutical manufacturing and advanced supply chains.
